It is a once-daily tablet containing semaglutide, the same active ingredient as the Wegovy injection, taken on an empty stomach with a specific routine (an absorption enhancer is used because semaglutide is normally broken down in the gut)
A recent meta-analysis found no link between GLP-1 agonists and pancreatitis in people with Type 2 diabetes, but some case reports challenge this
The opposite pattern, losing limb circumference while waist remains stable, suggests muscle loss that requires intervention
None of the approved GLP-1 or dual-agonist products carries a dermatologic indication, and the largest relevant real-world study, a target trial emulation with matched cohorts of 169,630 each, found no significant differences for inflammatory or autoimmune skin outcomes other than psoriasis, pemphigus and bullous pemphigoid after correction for multiple testing
Nat Med (2022) 28:5918
If you have commercial insurance through an employer, you are not eligible for the BALANCE demonstration program
